Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAM17 | P78536 | 1/20 | 0.46 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.32 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.30 |
| ▸ | APP | P05067 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 2/20 | 0.30 |
| ▸ | MMP9 | P14780 | 2/20 | 0.30 |
| ▸ | ANPEP | P15144 | 2/20 | 0.30 |
| ▸ | LTA4H | P09960 | 1/20 | 0.30 |
| ▸ | LAP3 | P28838 | 1/20 | 0.30 |
| ▸ | NPEPPS | P55786 | 1/20 | 0.30 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.30 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6988555 | 0.92 | ADAM17 (0.45) | ADAM17TGFBR1P2RX3APPMMP2 | |
| SCHEMBL6945800 | 0.92 | ADAM17 (0.47) | ADAM17TGFBR1P2RX3APPMMP2 | |
| SCHEMBL6945376 | 0.91 | ADAM17 (0.49) | ADAM17TGFBR1P2RX3APPMMP2 | |
| SCHEMBL6945370 | 0.91 | ADAM17 (0.49) | ADAM17TGFBR1P2RX3APPMMP2 | |
| SCHEMBL6984225 | 0.91 | ADAM17 (0.45) | ADAM17TGFBR1P2RX3 | |
| SCHEMBL6944451 | 0.90 | ADAM17 (0.47) | ADAM17TGFBR1P2RX3APPMMP2 | |
| SCHEMBL6946853 | 0.90 | ADAM17 (0.50) | ADAM17TGFBR1P2RX3APPMMP2 | |
| SCHEMBL6984710 | 0.89 | ADAM17 (0.45) | ADAM17TGFBR1P2RX3 | |
| SCHEMBL6983166 | 0.89 | ADAM17 (0.42) | ADAM17TGFBR1MMP2MMP9 | |
| SCHEMBL6988787 | 0.89 | ADAM17 (0.47) | ADAM17TGFBR1P2RX3APPMMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1089964-B1 | HYDRAZINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2003-10-29 | — | — | EP | disclosed |
| US-6239151-B1 | TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES, OSTEOARTHRITIS, RESPIRATORY DISEASES, TUMORS, CACHEXIA, CARDIOVASCULAR DISEASES, FEVER, HAEMORRHAGE AND SEPSIS, HYDRAZINE DERIVATIVES, | HOFFMANN-LA ROCHE INC. | 2001-05-29 | — | — | US | disclosed |
| EP-1089964-A1 | HYDRAZINE DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2001-04-11 | — | — | EP | disclosed |
| WO-2000000465-A1 | HYDRAZINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2000-01-06 | — | — | WO | disclosed |